New EU project aims to advance pandemic preparedness

With viral disease emergence expected to accelerate, preparing for possible future pandemics is paramount.

BioMarin shakes up executive team, tapping notable dealmaker James Sabry

BioMarin is bringing prominent dealmaker James Sabry onto its executive team, along with Amgen rare disease veteran Greg Friberg. Sabry will start on Oct. 7

August 22, 2024

Moncef Slaoui joins board at mRNA biotech; Gamida Cell retools with ex-Amryt CEO at the helm

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

June 22, 2024

Research links COVID-19 vaccines to temporary facial palsy in over 5,000 patients

This research identifies a potential link between COVID-19 vaccines and facial palsy, calling for enhanced surveillance and understanding of vaccine safety.

October 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.